Vor Biopharma Inc.

NASDAQ:VOR

Biotechnology

Healthcare
$17.83 -2.26%

-$0.34 today

Market cap
$966.13M
Beta
1.73
P/E (TTM)
-0.0
EPS (TTM)
-$2,053.13
52W Low $4.28High $65.80

Volume 0.79M

Average 1.07M

VOR Tax Payables

Taxes owed to authorities that have not yet been paid.

Vor Biopharma Inc.NASDAQ: VOR

Tax Payables · Q1 FY2026 · quarter ended Mar 2026

Tax payables remains negative

Q1 FY2026 tax payables was $0, compared with $0 a year earlier.

Context

  • Tax payables amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Tax payables increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Tax Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Tax Payables history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Tax Payables vs competitors

How VOR compares with its peers on the latest reported figures

  • VOR's Mar 2026 tax payables of $0 is the highest of the 10 companies compared; the peer median is $0.
  • Tax payables amounts to 0.0% of total assets for VOR, versus a peer median of 0.0%.
VOR Competitors Peer median
Tax Payables for VOR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
VORVor Biopharma Inc.Mar 2026$0 ——0.0%
CRSPCRISPR Therapeutics AGSep 2026$0 -100.0%—0.0%
NTLAIntellia Therapeutics, Inc.Mar 2026$0 ——0.0%
SANASana Biotechnology, Inc.Mar 2026$0 ——0.0%
EDITEditas Medicine, Inc.Mar 2026$0 ——0.0%
AUTLAutolus Therapeutics plcMar 2026$0 -100.0%—0.0%
IPSCCentury Therapeutics, Inc.Mar 2026$0 ——0.0%
RCKTRocket Pharmaceuticals, Inc.Mar 2026$0 ——0.0%
FATEFate Therapeutics, Inc.Mar 2026$0 ——0.0%
NKTXNkarta, Inc.Mar 2026$0 ——0.0%
Peer median (excluding VOR) $0-100.0%—0.0%

Competitors are the stored peer set for VOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents119.8M57.71M31.36M81.95M396.49M
Short-term Investments87.67M172.54M105.82M9.98M58.72M
Net Receivables00000
Inventory00000
Other Current Assets2.09M2.34M475K380K1.75M
Total Current Assets214.4M236.95M140.8M96.51M458.11M
Property, Plant & Equipment (Net)22.52M57.08M50.1M41.59M3.47M
Goodwill00000
Intangible Assets00000
Long-term Investments02.41M2.41M00
Tax Assets0011.7M00
Other Non-current Assets5.67M2.93M4.81M4.8M2.55M
Total Non-current Assets28.19M62.42M69.03M46.38M6.02M
Total Assets242.59M299.37M209.83M142.89M464.13M
Account Payables1.55M1.77M815K1.51M5.13M
Short-term Debt003.83M0280K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities434K4.95M4.97M6.21M15.33M
Total Current Liabilities10.15M13.12M15.57M18.61M25.17M
Long-term Debt00000
Deferred Tax Liabilities0011.7M00
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0000600.55M
Total Non-current Liabilities16.17M35.64M43.53M27.62M603.27M
Total Liabilities26.33M48.76M59.1M46.23M628.44M
Common Stock4K7K7K13K18K
Retained Earnings(130.12M)(222.22M)(340.08M)(456.99M)(1.15B)
Accumulated OCI0(770K)(77K)22K41K
Other Stockholders Equity(1K)0000
Minority Interest00000
Total Equity216.26M250.61M150.72M96.66M(164.31M)
Total Debt18.01M38.91M35.66M31.83M3M
Net Debt(101.79M)(18.79M)4.3M(50.12M)(393.49M)

Vor Biopharma Inc.

NASDAQ:VOR

Intrinsic Alpha fair value

Locked

Current Price

$17.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.